Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)

Eric L. Simpson, Abhijit Gadkari, Margitta Worm, Weily Soong, Andrew Blauvelt, Laurent Eckert, Richard Wu, Marius Ardeleanu, Neil M.H. Graham, Gianluca Pirozzi, E. Rand Sutherland, Vera Mastey

Research output: Contribution to journal › Article › peer-review

137 Scopus citations

Fingerprint

Dive into the research topics of 'Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)'. Together they form a unique fingerprint.

Medicine & Life Sciences